Summary
Over 3.1 million bottles of eye drops have been recalled across the United States due to concerns about their sterility. The U.S. Food and Drug Administration (FDA) has given the recall a Class II risk level, which means the products might cause temporary or reversible health problems. The recall was initiated by K.C. Pharmaceuticals and involves its products sold under various brand names in major stores.
Key Facts
- Over 3.1 million eye drop bottles are recalled due to sterility concerns.
- The FDA classified the recall as Class II, indicating possible temporary health issues.
- K.C. Pharmaceuticals, based in California, voluntarily began the recall.
- Products were distributed nationwide under various brand names.
- Major retailers involved include Walgreens, Kroger, CVS, and more.
- Recall details include specific lot numbers and expiration dates.
- The recall started on March 3, 2026, with the FDA's classification on March 31, 2026.
- No official press release has been issued by the company about the recall.
